Crestline Management’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-160,347
| Closed | -$6.78M | – | 623 |
|
|
2024
Q4 | $6.78M | Buy |
160,347
+79,032
| +97% | +$3.34M | 0.23% | 97 |
|
|
2024
Q3 | $3.59M | Buy |
81,315
+17,765
| +28% | +$785K | 0.19% | 132 |
|
|
2024
Q2 | $2.3M | Buy |
63,550
+11,958
| +23% | +$433K | 0.18% | 124 |
|
|
2024
Q1 | $2.22M | Sell |
51,592
-8,477
| -14% | -$366K | 0.2% | 124 |
|
|
2023
Q4 | $924K | Buy |
60,069
+14,689
| +32% | +$226K | 0.08% | 146 |
|
|
2023
Q3 | $622K | Hold |
45,380
| – | – | 0.07% | 133 |
|
|
2023
Q2 | $728K | Buy |
45,380
+16,013
| +55% | +$257K | 0.08% | 144 |
|
|
2023
Q1 | $228K | Buy |
+29,367
| New | +$228K | 0.03% | 150 |
|